Brief: CytRx Corp provides business update and highlights future plans
Oct 2 (Reuters) - CytRx Corp CYTR.O
* CytRx Corp provides business update and highlights future
plans
* CytRx Corp - hopes to nominate next Linker Activated Drug
Release discovery platform candidate for clinical development by
end of 2017
* CytRx Corp - CytRx ended Q2 of 2017 with $55 million in
cash
* CytRx Corp - restructured and paid down $10 million of its
existing debt during Q3
Source text for Eikon: ID:nPn8ZFBQra
Further company coverage: CYTR.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C